Development
Treatment.com AI Inc.
TREIF
$0.3496
-$0.0034-0.96%
OTC PK
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 85.71% | -81.58% | |||
| Gross Profit | -85.71% | 81.58% | |||
| SG&A Expenses | -14.86% | -60.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.22% | -61.63% | |||
| Operating Income | 14.22% | 61.63% | |||
| Income Before Tax | 13.37% | 61.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.37% | 61.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.37% | 61.27% | |||
| EBIT | 14.22% | 61.63% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 13.14% | 61.35% | |||
| Normalized Basic EPS | 13.30% | 61.36% | |||
| EPS Diluted | 13.14% | 61.35% | |||
| Normalized Diluted EPS | 13.30% | 61.36% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||